Acknowledgement
본 연구는 2022년도 정부(과학기술정보통신부)의 재원으로 한국연구재단의 지원(No. 2018R1A5A2025272)을 받아 수행되었습니다. 또한 과학기술정보통신부(MSIT)의 R&D 복귀자 프로그램에 따라 한국과학기술여성재단(WISET) 보조금의 지원(2021-014)을 받았습니다.
References
- Kisseleva T, Brenner DA. Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterology and Hepatology 2007;22(1):78-88. https://doi.org/10.1111/j.1440-1746.2006.04658.x
- Ramos-Tovar E, Muriel P. Molecular Mechanisms that link oxidative stress, inflammation, and fibrosis in the liver. Antioxidants 2020;9(12):1249.
- Xu J, Liu X, Koyama Y, Wang P, Lan T, Kim IG, et al. The type of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol 2014;5:167.
- Ozdemir-Kumral ZN, Erkek BE, Karakus B, Almaci M, Fathi R, Yuksel M, et al. Potential effect of 1,25 Dihydroxyvitamin D3 on thioacetamide-induced hepatotoxicity in rats. J Surg Res 2019;243:165-72. https://doi.org/10.1016/j.jss.2019.05.020
- Lee JA, Lee SH, Shin MR, Sook NJ, Roh SS. The Effect of Chaenomelis Fructus Extract on Thioacetamide-induced Fibrosis. JKSFSN 2021;50(4):322-9. https://doi.org/10.3746/jkfn.2021.50.4.322
- Muller A, Machnik F, Zimmermann T, Schibert H. Thioacetamide-induced cirrhosis-like liver lesions in rats-usefulness and reliability of this animal model. Exp Pathol 1998;34(4):229-36. https://doi.org/10.1016/S0232-1513(88)80155-5
- Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 2017;121:27-42. https://doi.org/10.1016/j.addr.2017.05.007
- Breitkopf K, Godoy P, Ciuclan L, Singer MV, Dooley S. TGF-beta/Smad signaling in the injured liver. Z Gastroenterol 2006;44(1):57-66. https://doi.org/10.1055/s-2005-858989
- Hassan HA. Oxidative stress as a crucial factor in liver associated disorders: Potential therapeutic effect of antioxidants. The Liver, Academic Press 2018:121-30.
- Lieber CS, Leo MA, Cao Q, Ren Cm Decarli LM. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol 2003;37(4):336-9. https://doi.org/10.1097/00004836-200310000-00013
- Jeong JH, Kim JH, Lee JD. A review on the medicinal potentials of Radix et Rhizoma Rhei. Journal of pharmacopuncture 2015;18(3):7-16.
- Kiruthga PV, Shafreen RB, Pandian SK, Devi KP. Silymarin protection against major reactive oxygen species released by environmental toxins: exogenous H2O2 exposure in erythrocytes. Basic Clin Pharmacol Toxicol 2007;100(6):414-9. https://doi.org/10.1111/j.1742-7843.2007.00069.x
- Di Costanzo A, Angelico R. Formulation strategies for Enhancing the Bioavailability of Silymarin: The state of the art. Molecules 2019;24(11):2155.
- Song JH, Yang TC, Chang KW, Han SK, Yi HK, Jeon JG. In vitro anti-cariogenic activity of dichloromethane fraction from Rheum undulatum L. root. Archives of pharmacal research 2006;29(6):490-6. https://doi.org/10.1007/BF02969422
- Hwang IY, Jeong CS. A study on the Antigastric effects of Rheum Species Extracts and Their Active Components. Journal of food Hygiene and safety 2013;2(4):330-6. https://doi.org/10.13103/JFHS.2013.28.4.330
- Folin O, Denis W. On phosphotungasticphosphomolybdic compounds as color reagent. Journal of biological chemisty 1912;12(2):239-43. https://doi.org/10.1016/S0021-9258(18)88697-5
- Lister CE, Lancaster JE, Sutton KH, Walker JR. Developmental changes in the concentration and composition of flavonoids in skin of a red and a green apple cultivar. Journal of the science of food and agriculture 1994;64(2):155-61. https://doi.org/10.1002/jsfa.2740640204
- Blois MS. Antioxidant determinations by the use of a stable free radical. Nature 1958;181(4617):1199-200. https://doi.org/10.1038/1811199a0
- Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorizationassay. Free Radical Biology and Medicine 1999;26(9-10):1231-7. https://doi.org/10.1016/S0891-5849(98)00315-3
- Park SM, Lee GW, Cho YH. Effect of rheum undulatum extract on antioxidant activity and activity of matrix metalloproteinase-1 in human skin fibroblasts. Journal of Life Science 2008;18(12):1700-4. https://doi.org/10.5352/JLS.2008.18.12.1700
- Schuppan D, Popov Y. Hepatic fibrosis: from bench to bedside. Journal Gastroenterol Hepatol 2002;17(3):300-5. https://doi.org/10.1046/j.1440-1746.17.s3.18.x
- Sanchez-Valle V, Chavez-Tapia NC, Uribe M, Mendez-Sanchez N. Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem 2012;19(28):4850-60. https://doi.org/10.2174/092986712803341520
- Parola M. Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspect Med 2019;(65):37-55.
- Kren V, Walteriva D. Silybin and Silymarin new effects and applications. Biomed Papers 2005;149(1):29-41. https://doi.org/10.5507/bp.2005.002
- Li Q, Gao J, Pang X, Chen A, Wang Y. Molecular Mechanism of Action of Emodin: As an Anti-Cardiovascular Disease Drug. Frontiers in Pharmacology 2020;11:559607.
- Kim HJ, Kim SY, Shin SP, Yang YJ, Bang CS, Baik GH. Immunological measurement of aspartate/alanine aminotransferase in predicting liver fibrosis and inflammation. Korean J Intern Med 2020;35(2):320-30. https://doi.org/10.3904/kjim.2018.214
- Arriazu E, De Galarreta MR, Cubero FJ, Varela-Rey M, De Obanos MPP, Leung TM, et al. Extracellular Matrix and Liver Disease. Antioxid. Redox Signal 2014;21(7):1078-97. https://doi.org/10.1089/ars.2013.5697
- Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Seminars in Liver Disease 2005;25(4):419-31.
- Bataller R, Gines P, Nicolas JM, Gorbig MN, Garcia-Ramallo E, Gasull X, et al. AngiotensinII induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 2000;118(6):1149-56. https://doi.org/10.1016/S0016-5085(00)70368-4
- Bataller R, Schwabe RF, Choi TH, Tang L, Paik YH, Lindquit J, et al. NADPH oxidase signal transduces angiotensin II n in hepatic stellate cells and critical in hepatic fibrosis. J Clin Invest 2003;112(9):1383-94. https://doi.org/10.1172/JCI18212
- De Souza Basso B, Haute GV, Ortega-Ribera M, Luft C, Antunes GL, Bastos MS, et al. Methoxyeugenol deactivates hepatic stellate cells and attenuates liver fibrosis and inflammation through a PPAR-ɣ and NF-kB mechanism. Journal of Ethnopharmacol 2021;280:114433.